Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Pharmatech’s SBIR Grant finishes a successful first year, with an even brighter futureBy: Pharmatech Inc. This last year, Pharmatech developed a bio specimen protocol to do general molecular screenings that speeds up the process in which patients are connected with research institutes. This remarkably exact process improves the chance that a patient can find a study matching their requirements; A (Just-In-Time) Pharmatech has released a beta version of TrialPlus, a web-based access point for sites and sponsor to manage clinical The commencement of the year two portion of the SBIR grant exemplifies a great success, in which Pharmatech invites all of its sponsors and sites to partake. Pharmatech, headquartered in Denver, Colorado, is a Site Management Organization (SMO) and Contract Research Organization (CRO) with a focus on oncology clinical research. Through an organized network of cancer clinics, the company focuses on advancing the development of products for a broad range of pharmaceutical and biotechnology companies, and promoting the inclusion of clinical trials in the spectrum of patient treatment options. For more information about Pharmatech, please visit www.pharmatech.com. The project described is supported by Award Number R44CA144362 from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|